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Abstract
Heterokaryon formation and Rous sarcoma virus (RSV)-induction were studied by fusion
of RSV-transformed human embryonic cells with chick embryo ﬁbroblasts in the presence of
lysolecithin. Heterokaryon formation was observed by autoradiography. RSV-induction was iden-
tiﬁed by focus formation, electron microscopy and density gradient centrifugation of 3H-uridine-
labeled particles. The most effective concentration of lysolecithin for virus induction was 10
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ultraviolet-inactivated Sendai virus (UV-HVJ).
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Abstract. Heterokaryon formation and Rous sarcoma virus (RSV)-
inductionwere studied by fusion of RSV-transformed human embryo-
nic cells with chick embryo fibroblasts in the presence oflysolecithin.
Heterokaryon formation was observed by autoradiography. RSV-
induction was identified by focus formation, electron microscopy and
density gradient centrifugation of 3H-uridine-Iabeled particles. The
most effective concentration of lysolecithin for virus induction was
10,ug/106 cells/O.! ml. Efficiency of lysolecithin in virus induction was
not less than that of ultraviolet-inactivated Sendai virus (UV-HVJ).
Infection of rats with avian tumor viruses was first reported by Svet-
Moldavsky (1). It was soon confirmed in a variety of other mammalian species
including primates (2,3,4,5,6). These mammalian cells transformed by Rous
sarcoma virus (RSV) are generally non-permissive. Many problems remain to
be solved: (a) how does the viral genome exist in virally transformed non-
producing cells, (b) what factor(s) regulates the expression of early arid late
genes of viruses, (c) whether a repressor exists in mammalian cells and (d)
what kind of viral information is required to maintain the transformed state.
In biological studies of these transformed non-permissive cells, successes in
rescuing the viruses from these cells have been reported by various methods
(7-16). The procedures are established for virus induction in heterokaryons
formed by virally transformed non-permissive cells and permissive chick embryo
fibroblasts using ultraviolet (UV) inactivated or p-propiolactone-treated Sendai
virus (HVJ) (6, 17-20). However, several disadvantages are present, as even
if the HVJ is inactivated, it remains a virus. Since the virus was passaged in
chicken eggs for proliferation, contamination is possible of the Rous associated
virus (RAV). There is no standard method for virus stocking, and it is in-
evitable that the stocked virus lose some cell fusion capacity during" preserva-
tion. Furthermore, the introduction of virus particles into a somatic cell
during the fusion process may cause host cell alterations which are unknown
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at present. It is reported that the presence of inactivated HVJ may actually
inhibit the rescue of related viruses (21).
For these reasons, the author tried to find an effective method for virus
induction by cell fusion without using HVJ. Howell and Lucy (22), Lucy (23),
Keay et ai. (24), and Ahkong et ai. (25) observed that lysolecithin (LL), a
phospholipid, was capable of fusing somatic cells and that viable heterokaryo-
cytes and hybrid cells were produced through fusion in the presence of LL.
However, no report is available on the use of this cell fusion method for tumor
virus induction. In the present study, this cell fusion method with LL was
applied for rescuing the virus from RSV-transformed human cells.
MATERIALS AND METHODS
RSb cells. RSb cells were the clonal cell line (l3-RSb 8) established by Dr.
T. Kuwata, ChibaUniversity,Chiba,Japan,derived from human embryonic cells
(HuE 13 RS cells) which were successively transformed by the Schmidt-Ruppin
strain of Rous sarcoma virus (SR-RSY) and simian virus 40 (SY40) (26). These
cells were maintained in Eagle's minimumessential medium(MEM)supplement-
ed with 10% calf serum. This cell line was not productive ofSR-RSVnor SV4O.
But the presence ofRSVgenome in this cell line was verified by detecting weak
gs-antigen in the cell and by inducing RSV-producing Rous sarcoma by inocul-
ating the cells into the chick wing web (27).
Chick embryo fibroblasts (CEF). Fertilized C/B eggs of specific pathogen free
type were kindly provided by the Kanonji Institute of the Research Foundation
for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan. The
culture and focus assay followed the techniques in principle described by Vogt
(28). CuIturemedia were based on MEM with 10% tryptose phosphate broth,
10% calf serum, 0.5% chick serum, and l,ug/ml of Fungisone (Amphotericin B).
Sendai virus (HV.!J. This strain of HVJ was kindly provided by Dr. Yoshio
Okada, Research Institute of Microbial Diseases, Osaka University, Osaka,
Japan. The viruses were inoculated into chorioallantoic sacs of 10 day-old
chick embryos and incubated at 37°C for 72 hours. The eggs were maintained
at 0 to 4°C overnight and the allantoic fluid was collected and centrifuged at
34,880 x g for 30min. The sediment was resuspended in one twentieth the
original volume in modified Hanks solution, divided into 1mllots in test tubes
and stored at 0 to 4°C.
inactivation of HVJ with UV-light. Two ml of virus suspension (33,000
HAU/ml) in a plastic Petri dish (50mm in diameter) was placed at a distance of
13 cm from one 15 W germicidal tube (50cm in length) and exposed to UV-light
for 3min with shaking at 30 second intervals.
Preparation oflysolecithin solution. Preparation procedures were according
to Croce et al. (29). Lysolecithin (5.0mg) dissolved in 5ml of absolute ethanol
was placed in a screw-capped tube and incubated at 70 to 80°C for lOmin. This
solution was stored at 0 to 4°C as a stock solution. Aliquots of 0.5ml of stock
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solution were transferred into a closed tube and the flow of nitrogen was
directed into the tube until all the ethanolwas evaporated leaving sterilized LL
powder at the bottom of the tube. Absolute ethanol (0.05ml) was added to dis-
solve the LL and was followed with addition of PBS (-) solution containing
5mg BSA (fraction V) per 1ml to give a final concentration of 500pg/ml.
Fusion procedures. RSb cells (2.5 x 105) labeled with tritiated thymidine and
unlabeled CEF (7.5X 105) were mixed with each other in Hanks solution and
centrifuged at l60xg for 3min. The pellets were treated with 0.1 ml of LL at
various concentrations for 1min. The tubes were shaken to detach the pellets
from the bottom of the tubes, thus increasing the availability of the cells to LL.
The action ofLL was neutralized by addition of 0.1 ml of MEMcontaining30%
calf serum inactivated at 56°C for 30min to each tube. The samples were cen-
trifuged for 3 to 5min at l60xg at room temperature and incubated for an addi-
tional 10min at 38°C. The pellets were resuspended in 1ml of Hanks solution
and seeded in 60mm Petri dish with 3ml of growth medium.
Autoradiography. Two coverslips were placed in the 60mm Petri dish.
Twelve hours after seeding, the samples were fixed and treated with 2% perch-
loric acid at 4°C for 30min to remove non-polymerized nucleotides and washed
with running water for 1min. The coverslips were dried and dipped into 2-fold
diluted Sakura NR-M2 emulsion at 45°C in a dark room. After exposure for
10 days at room temperature, the samples were developed and fixed. Finally
theywere stained with 1% Giemsa stain at pH 5.8, dried and mounted in Bioleit
(Oken Shoji Co., Tokyo, Japan).
Fusion procedures usingUV-HV]. The cell fusion method followed in prin-
ciple the procedures described by Okada (30). RSb cells (2.5X 105) and CEF
(7.5x 105) were mixed with each other in a conical flask containing Earle's solu-
tion, then 0.2ml of UV-HVJ suspension (1 HAU/103 cells) was added. The
samplewas kept in an ice water bath for 20min and shaken mildly for an addi-
tional 20min at 37°C. The reaction mixture was transferred into 60mm Petri
dishes containing 4ml of growth medium and incubated at 38°C in a 5% CO2
atmosphere.
Electron microscopy. Monolayer culture of cells 9 days after the cell fusion
reaction was washed with PBS solution, and the cells were fixed in 2.5% gluta-
raldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, for 30 to 60min for elec-
tron microscopy.
Focus assay of released viruses. Assay procedures followed in principle
those ofVogt (28). Nine days after the cell fusion reaction, the culture media
were replaced with 3ml of growth medium per 60mm plastic Petri dish. After
2 hrs incubation, the culture medium was collected and centrifuged at l60xg
for 3 min at room temperature, and 2ml of the supernatant were inoculated
into a monolayer culture of CEF allowed to settle 2 hours earlier. Two pg/ml
of polybrene were added to the assay system.
Virus purification. Labeling of viruses released from transformed foci with
3H-uridine was performed in growth medium. The labeled medium collected
at 4 hour intervals was frozen at -80°C until purification was performed.
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These pooled media were centrifuged at 1,300xg for 10 min to remove the
cellular debris. The viruses were purified from this supernatant according to
the method of Green et ai. (31). The concentrated virus solution was layered
on top of a linear sodium tartrate gradient (4 to 40% sodium tartrate, 0.15 M
NaGl, 0.015 M sodium citrate, pH 7.0) and centrifuged in a Hitachi RPS-65TA
rotor at 33,000 rpm for 2 hours. The 10 drop fractions were collected from the
bottom of the tube. Samples of 0.15ml each were added to 7.5ml of Bray's
scintillating solution for a radioactivity count with an Aroca spectrophoto-
meter.
RESULTS
Effect of LL on virus induction. Effects of LL concentration on virus induc-
tion are shown in Table 1. The effective concentration of LL on virus rescue
TABLE 1. EFFECTS OF UV-HVJ AND LYSOLECITHIN ON INDUCTION
OF RSV FROM MIXED CULTURES OF RSb CELLS AND CEF
Experiment UV-HVJa Lysolecithin ffu/2ml no. (/Lg/l()6cells)
1 None (-) 0
2 103 (-) 3
3 103 (-) 1
4- 103 (-) 0
5 103 (-) 5
6 None 5 3
7 None 10 7
8 None 15 7
9 None 25 0
10 None 50 0
a, Hemagglutination unit/106cells
ranged from 5 to 15,ugj106 cells/D.1ml on observation of focus formation in-
duced by these rescued viruses. Concentrations of more than 25,ug LL/106
cells/D.1m1 caused a cytolytic effect which resulted in stoppage of cell growth.
The transforming titer of cultured media from these mixed cells in the presence
of LL was low as shown in Table 1. But the effect of UV-BVJ on virus rescue
was not more than that of 10 to l5,ug LL. In cultures untreated withUV-BVJ
or LL, no focus formation was induced in the monolayer of CEF by addition
of polybrene. No addition of this compound resulted in no foci. Recently the
author succeeded in increasing the transformation titer of these viruses to 180
ffu/ml.
Autoradiography. Fig. 1 shows that LL induces multinucleated cell forma-
tion between RSb cells and CEF. The evidence for the multinucleated cells to
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Fig. 1. Autoradiograph of a heterokaryocyte of a tritiated thymidine-labeled
RSb cell and an unlabeled chick embryo fibroblast.
be heterokaryocytes is based on observations that nuclei with grains from
3H-thymidine incorporation were derived from RSb cells and other un-
labeled nuclei were derived from CEF. The percentage of polykaryocytes ob-
tained by LL treatment was approximately 17.5%. About 5.7 to 7.4% of RSb
cells were involved in heterokaryocyte formation with CEF in the presence of
LL. The frequency of spontaneously formed heterokaryocytes was negligible.
On the other hand, the frequency of heterokaryocyte formation induced by
UV-HVJ was at a level similar to that induced by LL, but the recovery of
viruses was low.
Electron microscopy. RSb cells and CEF were fixed in glutaraldehyde for
electron microscopic observations. Virus particles were not found in either type
of cell. Co-cultivation of RSb cells and CEF in the absence of LL or UV-HVJ
was also examined by electron microscopy. C-type virus particles were not
found. On the contrary, mixed cultures of both types of cells in the presence
of LL were fixed on the ninth day after cell fusion reaction. Electron micro-
scopic examination revealed the presence of C-type virus particles which were
in various phases, such as budding, immature and mature, as shown in Figs. 2
and 3. These C-type virus particles had spikes on their surfaces and their
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Figs. 2-3. Mature and budding C-type virus particles released from mixed
cultures of RSb cells and chick embryo fibroblasts in the presence of lysolecithin
(10 JLg/106cells/O.l mil. x 60,000.
diameters were about 100 mf.1.
Ultracentrifugal and enzymatic analyses. Ultracentrifuga1 analysis of cultured
media containing 3H-uridine was performed according to the procedures de-
scribed in Materials and Methods. It was proved that RNA viruses were
released from the foci formed on CEF by demonstrating the peak of radio-
activity at a density of l.17g/m1 (Fig. 4). The culture media fractions between
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Fig. 4. Sedimentation analysis of viruses released by cell fusion with lysoleci-
thin. Viruses were layered on a 4-40% w/v sodium tartrate gradient insse and
centrifuged at 33,000 rpm for 2 hours at 4°e in a Hitachi 65P RPS 65 TA rotor.
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5,000 X g and 100,000 X g had reverse transcriptase activity. These two pro-
perties are characteristics of RNA tumor viruses.
DISCUSSION
There are many procedures for rescuing viruses from virally transformed
non-productive mammalian cells, such as treatment with halogenated pyrimi-
dine (7, 10, 12, 13), UV-irradiation (14), decreased temperature (9), DNA
synthesis inhibitors (8, 11), co-cultivation with permissive cells (15, 16), cell
fusion with permissive cells in the presence of UV- or ,8-propiolactone treated
HVJ (17-20,32,33), inoculation of transformed cells directly into permissive
host animals to obtain the virus producing tumor (34) and transfection of iso-
lated DNA from transformed non-producing cells to monolayer culture of per-
missive cells (35-37).
Although these procedures have advantages they also have disadvantages.
It is thus necessary to select the method of virus rescue depending upon the
purpose of the experiment. Among these methods the one generally used is
cell fusion between transformed cells and permissive cells using UV-irradiated
HVJ. However, it has several disadvantages, especially in rescuing Rous
sarcoma virus. Since HVJ is a virus, other unexpected factors are present
which may cause some alterations in the cells. A loss of cell fusion capacity
may occur during storage. Meulen et al. (21) reported that the presence of UV-
HYJ inhibited the rescue of virus. For these reasons, the LL mediated cell
fusion technique introduced by Poole, Howell and Lucy (38) and Lucy (23)
was applied to rescue RSV from RSV-transformed human embryonic cells
(RSb).
As a result of this experiment, more viruses were recovered by LL than
by UV-HVJ, as described above. These findings show that lysolecithin, simple
phospholipid, is useful for virus rescue by cell fusion because of its relatively
simple action mechanism. The incidence of heterokaryocyte formation being
relatively low in contrast to homokaryocyte formation of both parent strain cells
may depend on the origin of the cell line. In the results of Poole, Howell and
Lucy, higher fusion efficiency was found with LL in an acid conditions (pH
5.5). Croce et ai. (29) found that hybrid formation after fusion was higher at
pH 7.2 than pH 5.5. The author has not performed the present experiment
under acid conditions. The LL concentrations used in the experiment of Croce
et ai. ranged from 200 to 600,ug/l07 cells/O.l ml. This LL level was too high
in my experimental system. The difference in the two studies may be due to
variations in the cell fusion capacity of LL itself.
It is important to determine the cytotoxicity of LL for every type of cell
used in cell fusion experiments. Another paper (39) reports that UV- or
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ft-propiolactone treated HVJ induced greater fusion efficiency and rescued more
viruses by using anti-HVJ serum.
In this experiment, RSb cells which contain low gs-antigen were used as
virogenic cells for the purpose of virus recovery from human cells. The
presence or absence of gs-antigen in CEF does not influence the outcome of
virus rescue (40). Gs-antigen negative non-productive RSV-transformed mam-
malian cells, however, cannot induce viruses by cell fusion even if the hetero-
karyocytes are superinfected with helper virus or treated with BUDR (40-41).
The limiting factor in virus rescue seems to be the degree of gs-antigen synthesis
in the mammalian cell (42-43). The mechanism of RSV rescue from hetero-
karyocytes is not yet clear. Chicken cell components of a heterokaryocyte might
complement certain functions of the mammalian cell which are necessary for
SR-RSV formation and/or they might cause de-repression of the same functions
of the mammalian cell.
Although subgroup determination of these rescued viruses has not been
completed, preliminary data indicates that the viruses may be classified in sub-
group D.
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